The efficacy of Cannabis Pulmonary inhaler in Managing Bronchospasm
It has been recognized for countless years that Cannabis— auto flowering seed, buds and other derived products from the plant is a bronchodilator and can be beneficial in managing asthma.
Normally, asthma is a difficulty with bronchospasm and thickened mucus generation in the tinier airways of the lungs. There is a consequential component of stress associated with asthma, as who would not be alarmed when it is hard to breathe. Higher anxiety causes serious bronchospasm, which causes more stress.
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a continuous inflammatory lung disease that blocks airflow to the lungs and makes it difficult to breathe. COPD is generally associated with the growth of emphysema and chronic bronchitis.
One of the foremost causes of mortality in the world is COPD— a group of lung complications that obstruct airflow and make it hard to breathe. Research shows that cannabis can aid patients to manage lunglike diseases by decreasing airway swelling and causing bronchodilation.
Studies have shown that THC may act as a temporary bronchodilator, particularly when ingested (about an hour or two). The New England Journal of Medicine published a 1973 study that stated, “Marijuana smoke, unlike cigarette smoke, causes bronchodilation rather than broncho-constriction— narrowing of the air passages, and, unlike opiates, does not cause central respiratory depression like a decrease in breathing.”
Effects of Cannabinoids and CBD on COPD
Considering stronger levels of Tetrahydrocannabinol (THC) can cause elevated anxiety, using Cannabidiol (CBD) looks like a prudent point to try. Taking CBD by any means does result in reduced airway resistance.
Research and studies show that cannabis could potentially be therapeutically helpful for controlling acute attacks of airway compression due to inflammation, thereby playing as a preventative action for patients with COPD. Cannabis has been explained through numerous studies to have effectiveness for decreasing inflammation, suggesting it could be useful for improving unhealthy airways in those with chronic bronchitis.
Two of the significant cannabinoids found in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) have noted in various research and studies to have anti-inflammatory benefits through a type of mechanisms. THC and CBD associated with the endocannabinoid system cannabinoid receptors (CB1 and CB2) to help the body maintain homeostasis— the ability or tendency to keep the internal stability to counterbalance any environmental changes inside the human body. The activation of CB1 and CB2 receptors has given to reduce airway inflammation.
An advanced study concluded that CBD has a potent anti-inflammatory effect and also enhances lung function, recommending it could be a valuable therapeutic tool for the treatment of inflammatory lung diseases. In another study, CBD was shown to have anti-inflammatory results following acute lung injury. Studies have also noticed that terpenes, the aromatic compounds found in cannabis, show anti-inflammatory benefits aside from other enhancing effect of cannabis on human body
An added study done from 1985 to 2006, examined 5,000 individuals from different cities across America. The researchers interviewed the participants about their cannabis and cigarette use and tested lung function as well as the rate of air flow out of their lungs. To their curiosity, the researchers found that at low to average levels of cannabis smoking, lung volume and airflow rates both improved with each year (365 joints of marijuana per year), up until seven years (or 2,555 joints).
As studies show that CBD can be a controlling determinant of asthma, many patients across the globe use CBD to control their effects of asthma. Though asthma is not life-threatening to humans or does not kill a person, the symptoms that an asthma patient encounters is very dangerous, this can seldom result in mortality
Research presented in the 1970s at the University of California Los Angeles has explained that both inhaled and orally ingested cannabinoids produce bronchodilation for up to two hours after administration. Further studies by the Respiratory Pharmacology Laboratory in Paris have shown that CB1 receptor (affect and regulate the way other bodily systems function) activation hinders cholinergic reduction in a concentration-dependent fashion, proposing a possible mechanism for acute bronchodilation correlated with cannabis intake. Although smoked purple weed cannabis also has this effect, any combustion creates other lung irritants that would be counterproductive for COPD treatment.
It is a noteworthy to observe that the findings in several studies suggest that the inhaling of Cannabis may raise the prevalence of acute and chronic bronchitis due to nuisances entering the lungs. Massive smoking of Cannabis on its own can cause airway interference. These findings recommend that patients with COPD should adhere to cannabis products that are delivered through methods other than smoking.
CBD oil or vaporizing CBD as an inhaler can benefit people suffering from asthma in numerous ways. The daily dosing of CBD is expected to get a one of known measure medication in the human system to manage asthma more efficiently. Asthma patients can use CBD to enhance their overall functions of the body, significantly, the lungs.
Natalie Gray is a Biochemical Engineer. She works in the Research and Development team that focuses on the design and construction of unit processes. She is a recreational marijuana supporter and her love for organic chemistry brought her to medical cannabis. She grows her own flowers, working on different projects and study everything above and under cannabis roots.
For more awareness and news follow me @ https://www.facebook.com/profile.php?id=100033069654281
You must log in to post a comment.